Clinical Development

Ventiv in good health

Ventiv in good health

By Kirsty Barnes

Ventiv health reported a strong performance across all its business
units in the third quarter, with total revenues increasing by 44
per cent to $128.4 million (€107.6 million) compared to the third
quarter of 2004.

UK boost to biomanufacturing

UK boost to biomanufacturing

By Kirsty Barnes

SR Pharma, specializing in RNAi therapeutics, will be the first
company to use the new UK National Biomanufacturing Centre (NBC),
operated by contract manufacturing organization (CMO) Eden
Biodesign, when it opens on schedule early...

Western CROs get proactive

Western CROs get proactive

By Kirsty Barnes

Contract research organisations (CROs) are responding to the
looming threat of competition from India and China by moving
outside their traditional role of simply providing contract
services to drug companies.

Covalent improves 3Q finances

Covalent improves 3Q finances

By Kirsty Barnes

Covalent Group has improved its financial position on last year,
reporting a net revenue increase of 45 per cent for the third
quarter of 2005 with sales of $2.7 million, (€2.3 million) compared
to $1.9 million one year ago.

Follow us

Products

View more

Webinars